This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regulus Therapeutics Inc (RGLS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 37.33M 17.81M 40.55M 9.18M
Receivables 274.00K 79.00K 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 164.95M 117.18M 98.93M 38.67M
Property, Plant & Equipment, Gross 8.72M 7.50M 5.75M 4.61M
Accumulated Depreciation & Depletion 5.15M 3.73M 2.44M 1.50M
Property, Plant & Equipment, Net 3.57M 3.77M 3.31M 3.11M
Intangibles 1.15M 1.13M 1.15M 980.00K
Other Non-Current Assets 1.81M 987.00K 125.00K 125.00K
Total Non-Current Assets 6.53M 5.88M 4.59M 4.21M
Liabilities & Shareholder Equity
Total Assets 171.48M 123.06M 103.52M 42.88M
Accounts Payable 2.19M 1.17M 311.00K 501.00K
Short Term Debt 0.00 0.00 0.00 377.00K
Other Current Liabilities 0.00 0.00 0.00 206.00K
Total Current Liabilities 35.19M 10.37M 12.77M 12.85M
Long Term Debt 0.00 11.28M 10.13M 10.00M
Deferred Income Taxes 0.00 0.00 0.00 446.00K
Other Non-Current Liabilities 4.27M 7.96M 18.52M 17.95M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 4.27M 19.24M 28.66M 71.53M
Total Liabilities 39.47M 29.61M 41.42M 84.38M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 132.01M 93.46M 62.09M -41.49M
Common Par 49.00K 42.00K 36.00K 0.00
Additional Paid In Capital 267.93M 172.52M 122.53M 1.58M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -135.77M -79.09M -60.42M -43.01M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -197.00K -16.00K -52.00K -67.00K
Total Capitalization 132.01M 104.74M 72.23M -31.49M
Total Equity 132.01M 93.46M 62.09M -41.49M
Total Liabilities & Stock Equity 171.48M 123.06M 103.52M 42.88M
Total Common Shares Outstanding 48.94M 41.79M 35.83M 34.13M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 44.09M 38.48M 8.21M 15.18M
Diluted Weighted Shares Outstanding 44.09M 38.48M 8.21M 15.18M
Number of Employees 81 76 66 NA
Number of Part-Time Employees 4 0 6 NA

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RGLS Regulus Therapeutics Inc

Chart of RGLS

Analysts Ratings for RGLS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

RGLS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs